New Merck pill available soon to treat COVID

Miami, Florida – The drugmaker Merck is seeking emergency use authorization for the pill known as Molnupiravir.
A new breakthrough pill for treating people with Covid that was tested in South Florida may be available in a couple of months.
In clinical trials, the pill cut in half your chances of being hospitalized or dying if you contracted Covid, according to the company.
“It sounds miraculous if there are no side effects,“ said David Light who lives in South Florida.
A part of the clinical trials for the new pill was conducted at research centers in Miami, Hialeah, and Hallandale Beach.
At this time, if you get a bad case of Covid, your treatment options are Monoclonal Antibodies, which is an infusion for people at high risk of hospitalization.
Remdesivir is another therapy is the drug, which is an antiviral given intravenously for people who are hospitalized with Covid.
According to the doctor of pharmacy Miles Gilman “The new drug is designed to interrupt the genetic system.”
If Merck gets emergency approval for the pill, the FDA will issue guidelines on who should get it and when Gilman said.